Get the Stockscreener App
28.17
0.11%
-0.03
Sanuwave Health Inc stock is traded at $28.17, with a volume of 5,030.
It is down -0.11% in the last 24 hours and up +0.00% over the past month.
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
See More
Previous Close:
$28.20
Open:
$27.67
24h Volume:
5,030
Relative Volume:
5.60
Market Cap:
$240.41M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$27.08
$28.50
1-Week Range:
$26.00
$29.10
52-Week Range:
$26.00
$29.10
Sanuwave Health Inc Stock (SNWV) Company Profile
Name
Sanuwave Health Inc
Sector
Industry
Phone
770-419-7525
Address
3360 MARTIN FARM RD, SUWANEE
Compare SNWV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.20 | 400.55M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.73 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.68 | 115.41M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
5.25 | 66.99M | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
87.06 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Latest News
Sanuwave Health to uplist to the Nasdaq Global Market - MSN
AllPennyStocks.com News: Sanuwave Looking Over the Shoulder of Competitors in the Diabetic Foot Ulcer Industry - ACCESS Newswire
Why We're Not Concerned About SANUWAVE Health, Inc.'s (NASDAQ:SNWV) Share Price - Simply Wall St
SANUWAVE Health (NASDAQ:SNWV) shareholder returns have been splendid, earning 278% in 1 year - Yahoo Finance
Sanuwave Health to Uplist to the Nasdaq Global Market - OrthoSpineNews
Sanuwave Health Secures Coveted Nasdaq SpotWhat This Means for SNWV Investors - StockTitan
Can This Regenerative Medicine Pioneer Transform the $50B Wound Care Market? Key Investor Conference Ahead - StockTitan
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results - GlobeNewswire
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results - GlobeNewswire
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering - Yahoo Finance
Sanuwave Health announces 1-for-375 reverse stock split - Yahoo Finance
SANUWAVE Health Announces 1-For-375 Reverse Stock Split - StockTitan
SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results - The Globe and Mail
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer - GlobeNewswire
Eden Prairie-based Sanuwave Health seeks Nasdaq listing in SPAC deal - Star Tribune
SANUWAVE signs merger agreement with SEPA - Medical Device Network
SANUWAVE Health, Inc., a Leading Provider of FDA Approved - GlobeNewswire
Sanuwave appoints new CEO - Mass Device
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer - GlobeNewswire
SANUWAVE Health to Host Conference Call and Provide Business Update - The Globe and Mail
Sanuwave announces intent to acquire Celularity’s UltraMist - Mass Device
Sanuwave partners with The Mobile Health Company - Mass Device
Sanuwave Health inks dev deal with eKare for wound care integration - Mass Device
Sanuwave files for de novo FDA nod for DermaPace wound care device - Mass Device
Sanuwave trial misses efficacy endpoint but shows superiority at 24 weeks - Mass Device
Sanuwave Health Inc Stock (SNWV) Financials Data
There is no financial data for Sanuwave Health Inc (SNWV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.40%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):